Eastman Chemical (EMN) | Financial Analysis & Statements
Eastman Chemical Company Mid-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
2.0B
Gross Profit
338.0M
17.13%
Operating Income
146.0M
7.40%
Net Income
105.0M
5.32%
EPS (Diluted)
$0.92
Balance Sheet Metrics
Total Assets
14.9B
Total Liabilities
8.8B
Shareholders Equity
6.0B
Debt to Equity
1.46
Cash Flow Metrics
Operating Cash Flow
686.0M
Free Cash Flow
390.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Eastman Chemical Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 8.8B | 9.4B | 9.2B | 10.6B | 10.5B |
| Cost of Goods Sold | 6.9B | 7.1B | 7.1B | 8.4B | 8.0B |
| Gross Profit | 1.8B | 2.3B | 2.1B | 2.1B | 2.5B |
| Gross Margin % | 21.1% | 24.4% | 22.4% | 20.2% | 23.9% |
| Operating Expenses | |||||
| Research & Development | 255.0M | 250.0M | 239.0M | 264.0M | 254.0M |
| Selling, General & Administrative | 633.0M | 664.0M | 768.0M | 625.0M | 383.0M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 888.0M | 914.0M | 1.0B | 889.0M | 637.0M |
| Operating Income | 956.0M | 1.4B | 1.1B | 1.2B | 1.9B |
| Operating Margin % | 10.9% | 14.7% | 11.4% | 11.8% | 17.8% |
| Non-Operating Items | |||||
| Interest Income | 11.0M | 16.0M | 10.0M | 6.0M | 3.0M |
| Interest Expense | 219.0M | 216.0M | 225.0M | 188.0M | 198.0M |
| Other Non-Operating Income | -180.0M | -98.0M | 248.0M | -89.0M | -583.0M |
| Pre-tax Income | 568.0M | 1.1B | 1.1B | 977.0M | 1.1B |
| Income Tax | 93.0M | 170.0M | 191.0M | 181.0M | 215.0M |
| Effective Tax Rate % | 16.4% | 15.8% | 17.6% | 18.5% | 19.9% |
| Net Income | 475.0M | 908.0M | 896.0M | 796.0M | 867.0M |
| Net Margin % | 5.4% | 9.7% | 9.7% | 7.5% | 8.3% |
| Key Metrics | |||||
| EBITDA | 1.4B | 1.9B | 1.5B | 1.7B | 2.4B |
| EPS (Basic) | $4.14 | $7.75 | $7.54 | $6.42 | $6.35 |
| EPS (Diluted) | $4.10 | $7.67 | $7.49 | $6.35 | $6.25 |
| Basic Shares Outstanding | 114700000 | 116700000 | 118600000 | 123500000 | 134900000 |
| Diluted Shares Outstanding | 114700000 | 116700000 | 118600000 | 123500000 | 134900000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Eastman Chemical Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 566.0M | 837.0M | 548.0M | 493.0M | 459.0M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 737.0M | 791.0M | 826.0M | 957.0M | 1.1B |
| Inventory | 2.0B | 2.0B | 1.7B | 1.9B | 1.5B |
| Other Current Assets | 100.0M | 104.0M | 96.0M | 114.0M | 96.0M |
| Total Current Assets | 3.6B | 4.1B | 3.5B | 3.8B | 4.6B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 8.3B | 8.3B | 8.4B | 8.5B | 8.6B |
| Intangible Assets | 970.0M | 1.0B | 1.1B | 1.2B | 1.4B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 848.0M | 833.0M | 820.0M | 855.0M | 874.0M |
| Total Non-Current Assets | 11.2B | 11.1B | 11.2B | 10.9B | 10.9B |
| Total Assets | 14.9B | 15.2B | 14.6B | 14.7B | 15.5B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.2B | 1.3B | 1.2B | 1.3B | 1.2B |
| Short-term Debt | 586.0M | 450.0M | 541.0M | 1.1B | 747.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 452.0M | 428.0M | 270.0M | 288.0M | 376.0M |
| Total Current Liabilities | 2.7B | 2.7B | 2.6B | 3.3B | 3.0B |
| Non-Current Liabilities | |||||
| Long-term Debt | 4.2B | 4.6B | 4.3B | 4.0B | 4.4B |
| Deferred Tax Liabilities | 669.0M | 533.0M | 601.0M | 671.0M | 810.0M |
| Other Non-Current Liabilities | 891.0M | 923.0M | 954.0M | 856.0M | 727.0M |
| Total Non-Current Liabilities | 6.2B | 6.7B | 6.5B | 6.2B | 6.8B |
| Total Liabilities | 8.8B | 9.4B | 9.1B | 9.4B | 9.7B |
| Equity | |||||
| Common Stock | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M |
| Retained Earnings | 10.1B | 10.0B | 9.5B | 9.0B | 8.6B |
| Treasury Stock | 6.5B | 6.4B | 6.1B | 5.9B | 4.9B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 6.0B | 5.9B | 5.5B | 5.2B | 5.8B |
| Key Metrics | |||||
| Total Debt | 4.8B | 5.0B | 4.8B | 5.2B | 5.2B |
| Working Capital | 993.0M | 1.4B | 905.0M | 527.0M | 1.7B |
Balance Sheet Composition
Eastman Chemical Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 475.0M | 908.0M | 896.0M | 796.0M | 867.0M |
| Depreciation & Amortization | 513.0M | 509.0M | 498.0M | 477.0M | 538.0M |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -104.0M | -77.0M | 291.0M | 13.0M | -27.0M |
| Operating Cash Flow | 943.0M | 1.3B | 1.7B | 898.0M | 1.3B |
| Investing Activities | |||||
| Capital Expenditures | -546.0M | -599.0M | -828.0M | -611.0M | -555.0M |
| Acquisitions | 38.0M | 38.0M | 379.0M | 997.0M | 553.0M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -462.0M | -534.0M | -427.0M | 405.0M | -6.0M |
| Financing Activities | |||||
| Share Repurchases | -100.0M | -300.0M | -150.0M | -1.0B | -1.0B |
| Dividends Paid | -381.0M | -379.0M | -376.0M | -381.0M | -375.0M |
| Debt Issuance | 246.0M | 1.2B | 796.0M | 500.0M | 0 |
| Debt Repayment | -550.0M | -1.0B | -808.0M | -750.0M | -300.0M |
| Financing Cash Flow | -797.0M | -454.0M | -888.0M | -1.3B | -1.7B |
| Free Cash Flow | 424.0M | 688.0M | 541.0M | 351.0M | 1.0B |
| Net Change in Cash | -316.0M | 348.0M | 344.0M | -18.0M | -379.0M |
Cash Flow Trend
Eastman Chemical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
17.58
Forward P/E
10.58
Price to Book
1.38
Price to Sales
0.94
PEG Ratio
-0.26
Profitability Ratios
Profit Margin
5.42%
Operating Margin
7.20%
Return on Equity
7.99%
Return on Assets
3.98%
Financial Health
Current Ratio
1.37
Debt to Equity
84.41
Beta
1.17
Per Share Data
EPS (TTM)
$4.10
Book Value per Share
$52.27
Revenue per Share
$76.30
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| EMN | 8.2B | 17.58 | 1.38 | 7.99% | 5.42% | 84.41 |
| Linde plc | 236.5B | 34.73 | 6.16 | 17.82% | 20.30% | 70.63 |
| Sherwin-Williams | 83.7B | 32.88 | 18.09 | 59.39% | 10.90% | 306.06 |
| Element Solutions | 9.3B | 48.25 | 3.46 | 7.51% | 7.48% | 64.06 |
| Arcadium Lithium plc | 6.3B | 64.89 | 1.00 | 2.78% | 10.24% | 14.03 |
| Axalta Coating | 6.3B | 17.05 | 2.70 | 17.43% | 7.39% | 138.36 |
Financial data is updated regularly. All figures are in the company's reporting currency.






